Literature DB >> 17429066

Increased apoptosis and skewed differentiation in mouse embryonic stem cells lacking the histone methyltransferase Mll2.

Sandra Lubitz1, Stefan Glaser, Julia Schaft, A Francis Stewart, Konstantinos Anastassiadis.   

Abstract

Epigenetic regulation by histone methyltransferases provides transcriptional memory and inheritable propagation of gene expression patterns. Potentially, the transition from a pluripotent state to lineage commitment also includes epigenetic instructions. The histone 3 lysine 4 methyltransferase Mll2/Wbp7 is essential for embryonic development. Here, we used embryonic stem (ES) cell lines deficient for Mll2 to examine its function more accurately. Mll2-/- ES cells are viable and retain pluripotency, but they display cell proliferation defects due to an enhanced rate of apoptosis. Apoptosis was not relieved by caspase inhibition and correlated with decreased Bcl2 expression. Concordantly, Mll2 binds to the Bcl2 gene and H3K4me(3) levels are reduced at the binding site when Mll2 is absent. In vitro differentiation showed delays along representative pathways for all three germ layers. Although ectodermal delays were severe and mesodermal delays persisted at about three days, endodermal differentiation seemed to recover and overshoot, concomitant with prolonged Oct4 gene expression. Hence, Mll2 is not required for ES cell self-renewal or the complex changes in gene expression involved in lineage commitment, but it contributes to the coordination and timing of early differentiation decisions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17429066      PMCID: PMC1877088          DOI: 10.1091/mbc.e06-11-1060

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  59 in total

1.  Histone methyltransferase activity of a Drosophila Polycomb group repressor complex.

Authors:  Jürg Müller; Craig M Hart; Nicole J Francis; Marcus L Vargas; Aditya Sengupta; Brigitte Wild; Ellen L Miller; Michael B O'Connor; Robert E Kingston; Jeffrey A Simon
Journal:  Cell       Date:  2002-10-18       Impact factor: 41.582

2.  Conversion of embryonic stem cells into neuroectodermal precursors in adherent monoculture.

Authors:  Qi-Long Ying; Marios Stavridis; Dean Griffiths; Meng Li; Austin Smith
Journal:  Nat Biotechnol       Date:  2003-01-13       Impact factor: 54.908

3.  Role of histone H3 lysine 27 methylation in Polycomb-group silencing.

Authors:  Ru Cao; Liangjun Wang; Hengbin Wang; Li Xia; Hediye Erdjument-Bromage; Paul Tempst; Richard S Jones; Yi Zhang
Journal:  Science       Date:  2002-09-26       Impact factor: 47.728

4.  Engineering the mouse genome with bacterial artificial chromosomes to create multipurpose alleles.

Authors:  Giuseppe Testa; Youming Zhang; Kristina Vintersten; Vladimir Benes; W W M Pim Pijnappel; Ian Chambers; Andrew J H Smith; Austin G Smith; A Francis Stewart
Journal:  Nat Biotechnol       Date:  2003-03-10       Impact factor: 54.908

5.  Mammalian Trithorax and polycomb-group homologues are antagonistic regulators of homeotic development.

Authors:  R D Hanson; J L Hess; B D Yu; P Ernst; M van Lohuizen; A Berns; N M van der Lugt; C S Shashikant; F H Ruddle; M Seto; S J Korsmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

6.  Stage-specific expression of alpha1,2-fucosyltransferase and alpha1, 3-fucosyltransferase (FT) during mouse embryogenesis.

Authors:  N Liu; C Jin; Z M Zhu; J Zhang; H Tao; C Ge; S Yang; S Zhang
Journal:  Eur J Biochem       Date:  1999-10-01

7.  Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein.

Authors:  Andrei Kuzmichev; Kenichi Nishioka; Hediye Erdjument-Bromage; Paul Tempst; Danny Reinberg
Journal:  Genes Dev       Date:  2002-11-15       Impact factor: 11.361

8.  MLL targets SET domain methyltransferase activity to Hox gene promoters.

Authors:  Thomas A Milne; Scott D Briggs; Hugh W Brock; Mary Ellen Martin; Denise Gibbs; C David Allis; Jay L Hess
Journal:  Mol Cell       Date:  2002-11       Impact factor: 17.970

9.  A p38 inhibitor allows to dissociate differentiation and apoptotic processes triggered upon LIF withdrawal in mouse embryonic stem cells.

Authors:  D Duval; M Malaisé; B Reinhardt; C Kedinger; H Boeuf
Journal:  Cell Death Differ       Date:  2004-03       Impact factor: 15.828

10.  G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis.

Authors:  Makoto Tachibana; Kenji Sugimoto; Masami Nozaki; Jun Ueda; Tsutomu Ohta; Misao Ohki; Mikiko Fukuda; Naoki Takeda; Hiroyuki Niida; Hiroyuki Kato; Yoichi Shinkai
Journal:  Genes Dev       Date:  2002-07-15       Impact factor: 11.361

View more
  49 in total

Review 1.  Trithorax group proteins: switching genes on and keeping them active.

Authors:  Bernd Schuettengruber; Anne-Marie Martinez; Nicola Iovino; Giacomo Cavalli
Journal:  Nat Rev Mol Cell Biol       Date:  2011-11-23       Impact factor: 94.444

Review 2.  Update on KMT2B-Related Dystonia.

Authors:  Michael Zech; Daniel D Lam; Juliane Winkelmann
Journal:  Curr Neurol Neurosci Rep       Date:  2019-11-25       Impact factor: 5.081

3.  Not All H3K4 Methylations Are Created Equal: Mll2/COMPASS Dependency in Primordial Germ Cell Specification.

Authors:  Deqing Hu; Xin Gao; Kaixiang Cao; Marc A Morgan; Gloria Mas; Edwin R Smith; Andrew G Volk; Elizabeth T Bartom; John D Crispino; Luciano Di Croce; Ali Shilatifard
Journal:  Mol Cell       Date:  2017-02-02       Impact factor: 17.970

Review 4.  Molecular implementation and physiological roles for histone H3 lysine 4 (H3K4) methylation.

Authors:  Ali Shilatifard
Journal:  Curr Opin Cell Biol       Date:  2008-05-26       Impact factor: 8.382

Review 5.  Histone demethylases and cancer.

Authors:  Sotirios C Kampranis; Philip N Tsichlis
Journal:  Adv Cancer Res       Date:  2009       Impact factor: 6.242

Review 6.  Hijacked in cancer: the KMT2 (MLL) family of methyltransferases.

Authors:  Rajesh C Rao; Yali Dou
Journal:  Nat Rev Cancer       Date:  2015-06       Impact factor: 60.716

Review 7.  Pluripotency and Epigenetic Factors in Mouse Embryonic Stem Cell Fate Regulation.

Authors:  Lluis Morey; Alexandra Santanach; Luciano Di Croce
Journal:  Mol Cell Biol       Date:  2015-06-01       Impact factor: 4.272

8.  Epigenetic regulator MLL2 shows altered expression in cancer cell lines and tumors from human breast and colon.

Authors:  Thanemozhi G Natarajan; Bhaskar V Kallakury; Christine E Sheehan; Margaret B Bartlett; Natarajan Ganesan; Anju Preet; Jeffrey S Ross; Kevin T FitzGerald
Journal:  Cancer Cell Int       Date:  2010-04-30       Impact factor: 5.722

9.  Cardiac deletion of Smyd2 is dispensable for mouse heart development.

Authors:  Florian Diehl; Mark A Brown; Machteld J van Amerongen; Tatyana Novoyatleva; Astrid Wietelmann; June Harriss; Fulvia Ferrazzi; Thomas Böttger; Richard P Harvey; Philip W Tucker; Felix B Engel
Journal:  PLoS One       Date:  2010-03-17       Impact factor: 3.240

10.  MLL2 is required in oocytes for bulk histone 3 lysine 4 trimethylation and transcriptional silencing.

Authors:  Claudia V Andreu-Vieyra; Ruihong Chen; Julio E Agno; Stefan Glaser; Konstantinos Anastassiadis; A Francis Stewart; Martin M Matzuk
Journal:  PLoS Biol       Date:  2010-08-17       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.